Magee B, Sheridan B, Scanlon M F, Atkinson A B
Clin Endocrinol (Oxf). 1986 Feb;24(2):209-15. doi: 10.1111/j.1365-2265.1986.tb00764.x.
A patient presented with mild hyperthyroidism, elevated serum T4 and T3, and an inappropriately raised serum thyrotrophin (TSH). There was no evidence of pituitary tumour (alpha-subunit secretion and CT scan of the pituitary were normal). The TSH response to TRH was greater than normal. The elevated TSH was suppressed by oral triiodothyronine (100 micrograms daily for 10 d). The normal diurnal variation of TSH was preserved. Intravenous injection of the dopamine receptor blocking agent domperidone led to a greater than normal elevation in TSH (maximum increments 18-20 mU/l). This increased dopaminergic tone was similar in studies carried out in the morning and late evening. The dopamine agonist bromocriptine (2.5 mg twice daily) failed to suppress serum TSH either acutely or over 6 weeks. The circadian rhythm was unaltered by this treatment. Basal serum prolactin levels were normal, and responded appropriately to TRH, domperidone and bromocriptine. These observations indicate that dopamine does not control the diurnal variation of TSH in nontumoral TSH-mediated hyperthyroidism. The increased dopaminergic tone demonstrated may be secondary to the primary failure of pituitary-thyroid feedback in the condition.
一名患者表现为轻度甲状腺功能亢进,血清T4和T3升高,血清促甲状腺激素(TSH)不适当升高。无垂体肿瘤证据(垂体α亚单位分泌及CT扫描正常)。TSH对促甲状腺激素释放激素(TRH)的反应高于正常。口服三碘甲状腺原氨酸(每日100微克,共10天)可抑制升高的TSH。TSH的正常昼夜变化得以保留。静脉注射多巴胺受体阻断剂多潘立酮导致TSH升高超过正常水平(最大增幅18 - 20 mU/l)。在早晨和傍晚进行的研究中,这种多巴胺能张力的增加情况相似。多巴胺激动剂溴隐亭(每日2次,每次2.5毫克)无论是急性给药还是在6周内均未能抑制血清TSH。这种治疗未改变昼夜节律。基础血清催乳素水平正常,对TRH、多潘立酮和溴隐亭反应正常。这些观察结果表明,在非肿瘤性TSH介导的甲状腺功能亢进中,多巴胺并不控制TSH的昼夜变化。所显示的多巴胺能张力增加可能是该疾病中垂体 - 甲状腺反馈原发性衰竭的继发结果。